Erin Bresnahan, MD
Peer Reviewed
With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
Eponyms: Janeway Lesions
July 22, 2021
By Zoe Lawrence, MD
Peer Reviewed
The patient is a 43-year-old intravenous drug user who presents to the emergency department with a few days of fevers and malaise. On exam, he is febrile …
Chiefs’ Inquiry Corner — 7/19/21
July 19, 2021- Tisch-Kimmel Inpatient: Does the addition of antimicrobial therapy confer any benefit on mortality or nonelective respiratory hospitalization in adults with idiopathic pulmonary fibrosis?
- Bellevue Inpatient: What are the guidelines/consensus statement on perioperative management of endocrine medications?
- VA Outpatient: Is there a relationship between intensity of statin therapy and muscle symptoms?
Is There A Role For Screening In Esophageal Adenocarcinoma?
July 16, 2021
By David Collins
Peer Reviewed
Esophageal adenocarcinoma (EA) is a rapidly growing risk to public health in the US, with nearly 17,000 new diagnoses and 16,000 EA deaths in 2017.1 Although treatment options …
Connected Distance
July 14, 2021
Clinical Correlations is proud to present our section for humanism in medicine, Tales from the Bedside, where we showcase our community’s unique and diverse experiences …
Chiefs’ Inquiry Corner – 7/12/21
July 12, 2021- NYU Brooklyn: What is the triad characterized by Felty Syndrome (FS)?
- Bellevue Inpatient: In patients with systemic lupus erythematosus (SLE), is there an increased risk for coronary artery disease?
- VA Outpatient: How should recent changes in guidelines affect our colorectal cancer (CRC) screening practices?
Chiefs’ Inquiry Corner – 7/7/21
July 7, 2021- NYU Brooklyn: What is the preferred treatment for management of C. Diff?
- Bellevue Inpatient: Can patients with statin-associated immune-mediated necrotizing myopathy (IMNM) with confirmed positive anti-HMG-CoA-reductase antibodies be re-challenged with statins or treated with PCSK9 inhibitors?
- Bellevue Outpatient: What is the role of GLP1-agonists when used for weight loss in patients without diabetes?
Primecuts – This Week in the Journals
May 14, 2021
By Kyra Hansson Floyd, MD
Peer Reviewed
With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor …